TWiM explains how ticagrelor alters the membrane of S. aureus and enhances the activity of vancomycin and daptomycin without eliciting cross-resistance, and the development of a novel continuous disinfectant technology that decreases healthcare-associated infections in ICUs by 70%.
Hosts: Vincent Racaniello, Michael Schmidt, and Michele Swanson.
Subscribe to TWiM (free) on Apple Podcasts, Spotify, Android, RSS, or by email.
Become a patron of TWiM.
Links for this episode
- Ticagrelor and S. aureus (mBio)
- Novel disinfectant technology (Am J Inf Control)
- UVC-LED to inactivate foodborne pathogens (Appl Envir Micro)
- UV disinfection systems (ACS Photonics)
- High-touch surfaces in specialized patient care area (CDC)
- Take the TWiM Listener survey!
